28.05.2015 Views

Research Week Abstract Book - Northern Health

Research Week Abstract Book - Northern Health

Research Week Abstract Book - Northern Health

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chronic Disease Management<br />

PRESCRIBING EVIDENCE-baseD MEDICINE IN HEART FAILURE: A PhysiCian-<br />

TARGETED INTERVENTION<br />

Chua C, Hutchinson A, Tacey M, Lim K, Aboltins C.<br />

Background<br />

Exacerbation of heart failure is a major cause of hospitalisation and readmissions worldwide. Despite strong evidence<br />

recommending the use of beta-blockers and angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor<br />

blockers (ARB) in chronic heart failure management, these medications have been under-utilised.<br />

Aim<br />

To evaluate the effectiveness of a quality improvement initiative targeted at physicians on prescription of beta-blockers and<br />

ACEi/ARB for heart failure management in a hospital setting.<br />

Methodology<br />

A prospective audit of medical records was conducted at The <strong>Northern</strong> Hospital between January 2009 and April 2012.<br />

Data regarding the use of beta-blockers and ACEi/ARB were randomly collected from approximately 10% of patients<br />

discharged every month from each general medical and aged care unit with a primary diagnosis of heart failure. A two-staged<br />

intervention was carried out. From November 2009 to December 2010, a heart failure management protocol was established<br />

and presented during Grand Rounds and junior doctor education sessions. The second stage commenced in February 2011<br />

and consist of three-monthly feedback meetings for each participating medical unit.<br />

Results<br />

A significant rise in the prescription rates for both beta-blockers (p=0.014) and ACEi/ARB (p=0.002) was identified in the<br />

first six months. However no further significant changes were seen during the remaining period of the initial intervention. The<br />

second stage of the intervention resulted in a significant upward trend for ACEi/ARB prescription rates (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!